In Vitro and In Silico Evaluation of New 1,3,4-Oxadiazole Derivatives of Pyrrolo[3,4-<i>d</i>]pyridazinone as Promising Cyclooxygenase Inhibitors.

Author: CzyżnikowskaŻaneta, PeregrymKrzysztof, PotyrakKatarzyna, SzczukowskiŁukasz, WiatrakBenita, ŚwiątekPiotr

Paper Details 
Original Abstract of the Article :
Since long-term use of classic NSAIDs can cause severe side effects related mainly to the gastroduodenal tract, discovery of novel cyclooxygenase inhibitors with a safe gastric profile still remains a crucial challenge. Based on the most recent literature data and previous own studies, we decided to...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8431030/

データ提供:米国国立医学図書館(NLM)

A Novel Approach to Cyclooxygenase Inhibition: Targeting Inflammation with 1,3,4-Oxadiazole Derivatives

Inflammation, a complex biological response to injury or infection, plays a critical role in various diseases. Nonsteroidal anti-inflammatory drugs (NSAIDs) have long been used to manage inflammation, but their long-term use can lead to adverse effects, particularly on the gastrointestinal tract. This study explores the potential of novel 1,3,4-oxadiazole derivatives of pyrrolo[3,4-d]pyridazinone as cyclooxygenase (COX) inhibitors, aiming to develop safer and more effective anti-inflammatory agents. Researchers synthesized and evaluated the biological activity of 12 novel compounds, investigating their potential for inhibiting both COX-1 and COX-2 enzymes. The study's findings highlight the promising properties of these derivatives, demonstrating their potential as safer alternatives to traditional NSAIDs.

1,3,4-Oxadiazole Derivatives: A New Frontier in Anti-inflammatory Therapy

This study highlights the potential of 1,3,4-oxadiazole derivatives of pyrrolo[3,4-d]pyridazinone as promising COX inhibitors. These novel compounds demonstrate a favorable safety profile, exhibiting no cytotoxicity to human cells, and exhibit potent inhibitory activity against both COX-1 and COX-2 enzymes. The findings suggest that these derivatives may offer a safer and more effective approach to managing inflammation, potentially reducing the adverse effects associated with traditional NSAIDs.

Navigating Inflammation: Seeking Effective and Safe Treatment Options

If you are experiencing inflammation, consult a healthcare professional to discuss appropriate treatment options. Exploring novel anti-inflammatory agents, such as 1,3,4-oxadiazole derivatives, may offer a safer and more effective approach to managing your condition. Collaborating with your doctor is crucial for finding the most suitable treatment plan for your individual needs.

Dr. Camel's Conclusion

This study, like a desert explorer seeking a hidden oasis of anti-inflammatory relief, explores the potential of novel 1,3,4-oxadiazole derivatives to provide a safer and more effective approach to managing inflammation. These promising compounds could potentially pave the way for a new era of anti-inflammatory therapy, offering hope for a more comfortable and fulfilling life for those experiencing inflammation.

Date :
  1. Date Completed 2021-10-12
  2. Date Revised 2021-10-12
Further Info :

Pubmed ID

34502040

DOI: Digital Object Identifier

PMC8431030

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.